logo

For the Inventor, By the Inventor

Audubon, PA, United States of America

Edward R Bacon

This inventor holds 64 USPTO granted patents and 2 published patent applications and 6 EPO patents, primarily in Pharmaceutical Chemistry (CPC class 424-). Top assignees: Sterling Winthrop Inc., Cephalon, Inc., Amersham Health as. Active years: 1990-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edward R Bacon. Retrieved from https://idiyas.com/inventor/edward-r-bacon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 64 

% Patents Active = 75.0

 

Average Co-Inventor Count = 4.4

ph-index = 17

Forward Citations = 1,313(Granted Patents)

Forward Citations (Not Self Cited) = 1,265(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Rensselaer, NY (US) (1994)
  • East Greenbush, NY (US) (1990 - 1997)
  • Wayne, PA (US) (2000 - 2006)
  • Audobon, PA (US) (1993 - 2013)
  • Audubon, PA (US) (1994 - 2014)

Company Filing History:

goldMedal25 out of 206 
 
Sterling Winthrop Inc.
 patents
silverMedal19 out of 248 
 
Cephalon, Inc.
 patents
bronzeMedal3 out of 46 
 
Amersham Health as
 patents
4. 3 out of 18 
 
Amersham Plc
 patents
5. 3 out of 20 
 
Cephalon France
 patents
6. 3 out of 1,546 
 
Sanofi
 patents
7. 3 out of 692 
 
Sterling Drug Inc.
 patents
8. 2 out of 21,604 
 
Eastman-Kodak Company
 patents
9. 2 out of 35 
 
Nanosystems L.l.c.
 patents
10. 2 out of 162 
 
Nycomed Imaging as
 patents
11. 1 out of 1 
 
Nahosystems L.l.c.
 patent
12. 1 out of 101 
 
Pharmacopeia Inc.
 patents
13. 1 out of 16 
 
Sanofi Winthrop Inc.
 patents
14. 1 out of 8 
 
Teva Sante
 patents
where one patent can have more than one assignee

Years Active: 1990-2014

Loading Chart...
Loading Chart...
Areas of Expertise:
H3 Receptor Ligands
Imaging Contrast Agents
Tricyclic Derivatives
Spirocyclic Piperidine
Bicyclic Aromatic Compounds
Thioacetamides
X-ray Contrast Agents
Pyrimidine Derivatives
Iodinated Compounds
Pharmaceutical Compositions
Diagnostic Agents
Nanoparticulate Agents
64 patents (USPTO):Explore Patents
1. 8765779 - Tricyclic derivatives and their pharmaceutical use and compositions (2014-07-01),
2. 8673916 - [object Object] (2014-03-18),
3. 8648067 - [object Object] (2014-02-11),
4. 8586588 - Aryl pyridazinone derivatives and their use as H3 receptor ligands (2013-11-19),
5. 8513232 - Substituted spirocyclic piperidine derivatives as histamine-3 (H3) receptor ligands (2013-08-20),
6. 8354414 - Substituted bicyclic pyrimidines (2013-01-15),
7. 8314155 - Bicyclic aromatic sulfinyl derivatives (2012-11-20),
8. 8247414 - Pyridizinone derivatives and the use thereof as H3 inhibitors (2012-08-21),
9. 8153667 - Tricyclic aromatic and bis-phenyl sulfinyl derivatives (2012-04-10),
10. 7981907 - Thio-substituted biarylmethanesulfinyl derivatives (2011-07-19),
11. 7851468 - Substituted pyrazolo[3,4-d]pyrimidines (2010-12-14),
12. 7449481 - Thio-substituted biaryl-methanesulfinyl derivatives (2008-11-11),
13. 7423176 - Bicyclic aromatic sulfinyl derivatives (2008-09-09),
14. 7314875 - Tricyclic aromatic and bis-phenyl sulfinyl derivatives (2008-01-01),
15. 7268132 - Substituted thioacetamides (2007-09-11),

Title: Innovations and Contributions of Edward R. Bacon in Pharmaceutical Patents

Introduction

Edward R. Bacon, based in Audubon, Pennsylvania, is a prolific inventor with an impressive portfolio of 64 patents. His work primarily focuses on pharmaceutical innovations, particularly in the development of compounds aimed at treating various disorders. Through his extensive research and creativity, he has significantly contributed to the field of medicinal chemistry.

Latest Patents

Among his latest patents are groundbreaking developments in pharmaceutical compounds. One notable patent involves tricyclic derivatives and their pharmaceutical applications. This invention includes compounds of Formula I, covering all stereoisomers, mixtures of stereoisomers, and their salts. Additionally, he has unveiled methods for treating disorders mediated by histamine H receptors through novel pyridazinone derivatives. These compounds show promise in addressing conditions related to neurodegenerative disorders, sleep/wake disorders, attention deficit hyperactivity disorder, and cognitive disorders.

Career Highlights

Edward R. Bacon's career includes significant roles in reputable companies such as Sterling Winthrop Inc. and Cephalon, Inc. His work in these organizations has played a vital role in the advancement of pharmaceutical innovations, offering novel treatments and contributing to the healthcare sector's evolution.

Collaborations

Throughout his career, Edward has collaborated with accomplished professionals, including Kurt A. Josef and Carl R. Illig. These partnerships have fostered creativity and synergy in the development of his patented technologies, enabling the pursuit of innovative solutions in medicine.

Conclusion

Edward R. Bacon stands out as an influential inventor in the pharmaceutical field. His dedication to research and innovation is reflected in his numerous patents and collaborations. With continued advancements in his work, he remains a pivotal figure in the quest for effective treatments for complex disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…